From October 1, 2023 to December 31, 2023, the company has repurchased 140,158 shares, representing 0.46% for $0.16 million. With this, the company has completed the repurchase of 4,848,678 shares, representing 14.76% for $15.58 million under the buyback announced on March 15, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | +4.13% | +7.69% | -5.26% |
Apr. 12 | Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event | CI |
Apr. 04 | Co-Diagnostics, Inc. Appoints Executive Appointments | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.26% | 39.39M | |
-15.58% | 18.77B | |
-41.10% | 2.9B | |
+24.02% | 1.97B | |
+8.62% | 1.82B | |
+26.40% | 1.25B | |
-7.74% | 1.06B | |
-18.61% | 936M | |
-1.55% | 770M | |
-23.76% | 639M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.